COVID‐19–Induced Acute Pancreatitis: Clinical Profiles, Outcomes, and Prognostic Indicators From a Global Review‐Based Synthesis
Unlike "concurrent COVID-19 and AP (without excluding established AP etiologies)," "COVID-19-induced AP" showed no survival disparity by symptom chronology. Mortality was linked to leukocytosis, AST-to-ALT ratio, and surgical intervention. Standardized terminology distinguishing "COVID-19-induced AP" from "concurrent COVID-19 and AP" is essential to ensure comparability of global clinical data and reduce interpretive bias.
Authors
- Chen‐June Seak (ORCID: https://orcid.org/0000-0003-0984-8385)
- Tsung‐Hsing Chen (ORCID: https://orcid.org/0000-0001-8888-7985)
- Yu‐Jhou Chen (ORCID: https://orcid.org/0000-0002-1697-0891)
- Shu‐Wei Huang (ORCID: https://orcid.org/0000-0002-0237-7317)
- Hao‐Tsai Cheng (ORCID: https://orcid.org/0000-0002-5936-738X)
- Sen‐Yung Hsieh
- Chang‐Mu Sung
Institutions
- Chang Gung University of Science and Technology (TW)
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Taipei Municipal YangMing Hospital (TW)
- Linkou Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Health Science Reports
- Published
- 2025-10-28
- DOI
- https://doi.org/10.1002/hsr2.71417
- Primary Topic
- Pancreatitis Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chang Gung Medical Foundation